Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors.
Delcuratolo MD, Tucci M, Turco F, Di Stefano RF, Ungaro A, Audisio M, Samuelly A, Brusa F, Audisio A, Di Maio M, Scagliotti GV, Buttigliero C.
Delcuratolo MD, et al. Among authors: turco f.
Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24.
Crit Rev Oncol Hematol. 2023.
PMID: 36427772
Review.